{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:06:53Z","timestamp":1790208413000,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.arteri.2021.10.001","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T08:14:07Z","timestamp":1643962447000},"page":"S24-S31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"S1","title":["Dietary patterns in non-alcoholic fatty liver disease (NAFLD): Stay on the straight and narrow path!"],"prefix":"10.1016","volume":"34","author":[{"given":"Niki","family":"Katsiki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca Pantea","family":"Stoian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfredi","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arteri.2021.10.001_bib0335","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.arteri.2021.10.001_bib0340","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.arteri.2021.10.001_bib0345","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.3748\/wjg.v21.i22.6820","article-title":"Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: an update","volume":"21","author":"Athyros","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.arteri.2021.10.001_bib0350","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2174\/1570161117666190405164313","article-title":"Non-alcoholic fatty liver disease treatment in patients with type 2 diabetes mellitus; new kids on the block","volume":"18","author":"Athyros","year":"2020","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.arteri.2021.10.001_bib0355","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/1570161115666170621075619","article-title":"Is nonalcoholic fatty liver disease indeed the hepatic manifestation of metabolic syndrome?","volume":"16","author":"Katsiki","year":"2018","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.arteri.2021.10.001_bib0360","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jdiacomp.2016.12.006","article-title":"Non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: effects of statins and antidiabetic drugs","volume":"31","author":"Katsiki","year":"2017","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.arteri.2021.10.001_bib0365","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.metabol.2017.02.014","article-title":"The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis and related cardiovascular risk. An expert panel statement","volume":"71","author":"Athyros","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.arteri.2021.10.001_bib0370","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1080\/10408398.2020.1764487","article-title":"Dietary habits, lipoprotein metabolism and cardiovascular disease: from individual foods to dietary patterns","volume":"61","author":"Gomez-Delgado","year":"2021","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.arteri.2021.10.001_bib0375","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/bph.14778","article-title":"Mediterranean diet and health status: active ingredients and pharmacological mechanisms","volume":"177","author":"Schwingshackl","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.arteri.2021.10.001_bib0380","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.3390\/nu11112833","article-title":"The fluid aspect of the Mediterranean diet in the prevention and management of cardiovascular disease and diabetes: the role of polyphenol content in moderate consumption of wine and olive oil","volume":"11","author":"Ditano-V\u00e1zquez","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.arteri.2021.10.001_bib0385","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11886-021-01496-1","article-title":"Olive oil intake and cardiovascular disease prevention: \u201cseek and you shall find\u201d","volume":"23","author":"Katsiki","year":"2021","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.arteri.2021.10.001_bib0390","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1177\/0003319714532169","article-title":"Health benefits of the Mediterranean Diet: an update of research over the last 5 years","volume":"66","author":"Gotsis","year":"2015","journal-title":"Angiology"},{"key":"10.1016\/j.arteri.2021.10.001_bib0395","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3390\/nu13051442","article-title":"Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the role of sugary food consumption and other dietary components in its development","volume":"13","author":"Vancells Lujan","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.arteri.2021.10.001_bib0400","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.3748\/wjg.v24.i19.2083","article-title":"Mediterranean diet and nonalcoholic fatty liver disease","volume":"24","author":"Anania","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.arteri.2021.10.001_bib0405","first-page":"e15618","article-title":"The significance of the Mediterranean diet in the management of non-alcoholic fatty liver disease: a systematic review","volume":"13","author":"Gosal","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.arteri.2021.10.001_bib0410","article-title":"Effect of the Mediterranean diet on histological indicators and imaging tests in non-alcoholic fatty liver disease","author":"Saavedra","year":"2021","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.arteri.2021.10.001_bib0415","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.3390\/nu11122971","article-title":"Mediterranean diet and NAFLD: what we know and questions that still need to be answered","volume":"11","author":"Plaz Torres","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.arteri.2021.10.001_bib0420","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/liv.13435","article-title":"The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: evidence and plausible mechanisms","volume":"37","author":"Zelber-Sagi","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.arteri.2021.10.001_bib0425","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.clnesp.2020.03.003","article-title":"Effects of the Mediterranean diet on cardiovascular risk factors in non-alcoholic fatty liver disease patients: a systematic review and meta-analysis","volume":"37","author":"Asbaghi","year":"2020","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.arteri.2021.10.001_bib0430","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s40200-019-00475-2","article-title":"Mediterranean diet for patients with non-alcoholic fatty liver disease, a systematic review and meta-analysis of observational and clinical investigations","volume":"19","author":"Akhlaghi","year":"2020","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.arteri.2021.10.001_bib0435","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-0041-1723751","article-title":"Effects of Mediterranean diet in patients with nonalcoholic fatty liver disease: a systematic review meta-analysis, and meta-regression analysis of randomized controlled trials","volume":"41","author":"Kawaguchi","year":"2021","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.arteri.2021.10.001_bib0440","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.clnesp.2019.10.008","article-title":"The effect of a Mediterranean diet on metabolic parameters in patients with non-alcoholic fatty liver disease: a systematic review of randomized controlled trials","volume":"35","author":"Moosavian","year":"2020","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.arteri.2021.10.001_bib0445","first-page":"e13659","article-title":"Is there an \u2018ideal\u2019 diet for patients with NAFLD?","author":"Pugliese","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.arteri.2021.10.001_bib0450","doi-asserted-by":"crossref","first-page":"i4428","DOI":"10.1136\/bmj.i4428","article-title":"Guideline Development Group Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance","volume":"354","author":"Glen","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.arteri.2021.10.001_bib0455","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.arteri.2021.10.001_bib0460","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/obr.12391","article-title":"The effect of dietary approaches to stop hypertension (DASH) diet on weight and body composition in adults: a systematic review and meta-analysis of randomized controlled clinical trials","volume":"17","author":"Soltani","year":"2016","journal-title":"Obes Rev"},{"key":"10.1016\/j.arteri.2021.10.001_bib0465","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/nu11020338","article-title":"DASH dietary pattern and cardiometabolic outcomes: an umbrella review of systematic reviews and meta-analyses","volume":"11","author":"Chiavaroli","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.arteri.2021.10.001_bib0470","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.3390\/nu12123860","article-title":"Nutritional approaches for the management of nonalcoholic fatty liver disease: an evidence-based review","volume":"12","author":"Parra-Vargas","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.arteri.2021.10.001_bib0475","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1017\/S1368980019002568","article-title":"Adherence to the Dietary Approaches to Stop Hypertension (DASH) diet is associated with lower presence of non-alcoholic fatty liver disease in middle-aged and elderly adults","volume":"23","author":"Xiao","year":"2020","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.arteri.2021.10.001_bib0480","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1080\/09637486.2016.1210101","article-title":"Adherence to the Dietary Approaches to Stop Hypertension (DASH) and risk of nonalcoholic fatty liver disease","volume":"67","author":"Hekmatdoost","year":"2016","journal-title":"Int J Food Sci Nutr"},{"key":"10.1016\/j.arteri.2021.10.001_bib0485","doi-asserted-by":"crossref","first-page":"nzaa024","DOI":"10.1093\/cdn\/nzaa024","article-title":"Diet quality association with nonalcoholic fatty liver disease by cirrhosis status: the multiethnic cohort","volume":"4","author":"Park","year":"2020","journal-title":"Curr Dev Nutr"},{"key":"10.1016\/j.arteri.2021.10.001_bib0490","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3390\/nu12030825","article-title":"Dietary factors in relation to liver fat content: a cross-sectional study","volume":"12","author":"Watzinger","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.arteri.2021.10.001_bib0495","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/liv.12990","article-title":"The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial","volume":"36","author":"Razavi Zade","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.arteri.2021.10.001_bib0500","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/j.gastro.2009.01.048","article-title":"Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction","volume":"136","author":"Kirk","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.arteri.2021.10.001_bib0505","doi-asserted-by":"crossref","first-page":"e13024","DOI":"10.1111\/obr.13024","article-title":"Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: a comprehensive review of the literature","volume":"21","author":"Watanabe","year":"2020","journal-title":"Obes Rev"},{"key":"10.1016\/j.arteri.2021.10.001_bib0510","doi-asserted-by":"crossref","first-page":"7347","DOI":"10.1073\/pnas.1922344117","article-title":"Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease","volume":"117","author":"Luukkonen","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.arteri.2021.10.001_bib0515","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/jog.14650","article-title":"Ketogenic diet in women with polycystic ovary syndrome and liver dysfunction who are obese: a randomized, open-label, parallel-group, controlled pilot trial","volume":"47","author":"Li","year":"2021","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.arteri.2021.10.001_bib0520","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3389\/fendo.2020.00607","article-title":"Efficacy of a 2-month Very Low-Calorie Ketogenic Diet (VLCKD) compared to a standard low-calorie diet in reducing visceral and liver fat accumulation in patients with obesity","volume":"11","author":"Cunha","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.arteri.2021.10.001_bib0525","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.3390\/nu12092748","article-title":"Very low-carbohydrate ketogenic diet for the treatment of severe obesity and associated non-alcoholic fatty liver disease: the role of sex differences","volume":"12","author":"D\u2019Abbondanza","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.arteri.2021.10.001_bib0530","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2478\/jtim-2020-0005","article-title":"Ketogenic hypocaloric diet improves nonalcoholic steatohepatitis","volume":"8","author":"Belopolsky","year":"2020","journal-title":"J Transl Int Med"},{"key":"10.1016\/j.arteri.2021.10.001_bib0535","first-page":"e6605","article-title":"Ketogenic diet-induced elevated cholesterol elevated liver enzymes and potential non-alcoholic fatty liver disease","volume":"12","author":"Anekwe","year":"2020","journal-title":"Cureus."},{"key":"10.1016\/j.arteri.2021.10.001_bib0540","first-page":"374","article-title":"Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease","volume":"15","author":"Schugar","year":"2012","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.arteri.2021.10.001_bib0545","doi-asserted-by":"crossref","first-page":"100256","DOI":"10.1016\/j.jhepr.2021.100256","article-title":"Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet \u2013 a randomised controlled trial","volume":"3","author":"Holmer","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.arteri.2021.10.001_bib0550","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.3390\/nu11112601","article-title":"Effects of periodic fasting on fatty liver index \u2013 a prospective observational study","volume":"11","author":"Drinda","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.arteri.2021.10.001_bib0555","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s43066-021-00128-1","article-title":"Reversion to regular diet with alternate day fasting can cure grade-I non-alcoholic fatty liver disease (NAFLD) in high-fructose-intake-associated metabolic syndrome","volume":"11","author":"Gamil","year":"2021","journal-title":"Egypt Liver J"},{"key":"10.1016\/j.arteri.2021.10.001_bib0560","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12876-019-1132-8","article-title":"Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial","volume":"19","author":"Cai","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.arteri.2021.10.001_bib0565","doi-asserted-by":"crossref","first-page":"11232","DOI":"10.1038\/s41598-019-47763-8","article-title":"A randomised controlled trial on the effectiveness and adherence of modified alternate-day calorie restriction in improving activity of non-alcoholic fatty liver disease","volume":"9","author":"Johari","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.arteri.2021.10.001_bib0570","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1080\/07315724.2017.1339644","article-title":"The effects of Ramadan fasting on body composition, blood pressure glucose metabolism, and markers of inflammation in NAFLD patients: an observational trial","volume":"36","author":"Aliasghari","year":"2017","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.arteri.2021.10.001_bib0575","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1024\/0300-9831\/a000442","article-title":"Ramadan fasting improves liver function and total cholesterol in patients with nonalcoholic fatty liver disease","volume":"90","author":"Ebrahimi","year":"2020","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1016\/j.arteri.2021.10.001_bib0580","first-page":"94","article-title":"The impact of Ramadan fasting on fatty liver disease severity: a retrospective case control study from Israel","volume":"23","author":"Mari","year":"2021","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.arteri.2021.10.001_bib0585","doi-asserted-by":"crossref","first-page":"709683","DOI":"10.3389\/fnut.2021.709683","article-title":"Effect of intermittent fasting on non-alcoholic fatty liver disease: systematic review and meta-analysis","volume":"8","author":"Yin","year":"2021","journal-title":"Front Nutr"},{"key":"10.1016\/j.arteri.2021.10.001_bib0590","first-page":"102","article-title":"Vegetarian diet, food substitution, and nonalcoholic fatty liver","volume":"30","author":"Chiu","year":"2018","journal-title":"Ci Ji Yi Xue Za Zhi"},{"key":"10.1016\/j.arteri.2021.10.001_bib0595","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/jn\/nxy217","article-title":"Vegetarian diets are associated with selected cardiometabolic risk factors among middle-older aged south Asians in the United States","volume":"148","author":"Jin","year":"2018","journal-title":"J Nutr"},{"key":"10.1016\/j.arteri.2021.10.001_bib0600","first-page":"1","article-title":"Effects of lacto-ovo-vegetarian diet vs. standard-weight-loss diet on obese and overweight adults with non-alcoholic fatty liver disease: a randomised clinical trial","author":"Garousi","year":"2021","journal-title":"Arch Physiol Biochem"},{"key":"10.1016\/j.arteri.2021.10.001_bib0605","doi-asserted-by":"crossref","first-page":"81","DOI":"10.15403\/jgld-3064","article-title":"Vegan diet advice might benefit liver enzymes in nonalcoholic fatty liver disease: an open observational pilot study","volume":"30","author":"Chiarioni","year":"2021","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.arteri.2021.10.001_bib0610","doi-asserted-by":"crossref","first-page":"336","DOI":"10.5152\/tjg.2015.0046","article-title":"A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): a cross-sectional study between Buddhist priests and the general population","volume":"26","author":"Choi","year":"2015","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.arteri.2021.10.001_bib0615","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.clnu.2018.08.010","article-title":"Higher adherence to plant-based diets are associated with lower likelihood of fatty liver","volume":"38","author":"Mazidi","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.arteri.2021.10.001_bib0620","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3350\/cmh.2020.0067","article-title":"Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH","volume":"26","author":"Hydes","year":"2020","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.arteri.2021.10.001_bib0625","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1476-511X-13-160","article-title":"Favourable effects of consuming a Palaeolithic-type diet on characteristics of the metabolic syndrome: a randomized controlled pilot-study","volume":"13","author":"Boers","year":"2014","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.arteri.2021.10.001_bib0630","doi-asserted-by":"crossref","first-page":"359","DOI":"10.15403\/jgld.2014.1121.243.gta","article-title":"Hype or reality: should patients with metabolic syndrome-related NAFLD be on the Hunter-Gatherer (Paleo) diet to decrease morbidity?","volume":"24","author":"Tarantino","year":"2015","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.arteri.2021.10.001_bib0635","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3945\/ajcn.115.113613","article-title":"Paleolithic nutrition for metabolic syndrome: systematic review and meta-analysis","volume":"102","author":"Manheimer","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.arteri.2021.10.001_bib0640","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/ijo.2016.4","article-title":"Strong and persistent effect on liver fat with a Paleolithic diet during a two-year intervention","volume":"40","author":"Otten","year":"2016","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.arteri.2021.10.001_bib0645","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/joim.12048","article-title":"A Palaeolithic-type diet causes strong tissue-specific effects on ectopic fat deposition in obese postmenopausal women","volume":"274","author":"Ryberg","year":"2013","journal-title":"J Intern Med"},{"key":"10.1016\/j.arteri.2021.10.001_bib0650","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1007\/s00125-018-4618-y","article-title":"A heterogeneous response of liver and skeletal muscle fat to the combination of a Paleolithic diet and exercise in obese individuals with type 2 diabetes: a randomised controlled trial","volume":"61","author":"Otten","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.arteri.2021.10.001_bib0655","article-title":"MAFLD: renovation of clinical practice and disease awareness of fatty liver","author":"Kawaguchi","year":"2021","journal-title":"Hepatol Res"},{"key":"10.1016\/j.arteri.2021.10.001_bib0660","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/nutrit\/nux014","article-title":"Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation","volume":"75","author":"P\u00e9rez-Mart\u00ednez","year":"2017","journal-title":"Nutr Rev"}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916821001558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916821001558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:33:23Z","timestamp":1759325603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916821001558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":66,"alternative-id":["S0214916821001558"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2021.10.001","relation":{},"ISSN":["0214-9168"],"issn-type":[{"value":"0214-9168","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dietary patterns in non-alcoholic fatty liver disease (NAFLD): Stay on the straight and narrow path!","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2021.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Arteriosclerosis. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}